Johnson & Johnson
BASEJohnson & Johnson is finding its footing after last week's retreat, but the borrow cost anomaly that defined the prior note has not resolved — and that tension remains the most interesting thread heading into October earnings. The price action this week is a modest recovery. JNJ added roughly 1% on the week to close at what the ARS-denominated data shows as 27,300 — though it bears…
Snapshot as of 8 Aug 2026
A new long-form analysis for JNJ this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumJohnson & Johnson is finding its footing after last week's retreat, but the borrow cost anomaly that defined the prior note has not resolved — and that tension remains the most interesting thread heading into October…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JNJ — free to start on ORTEX.
